HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Bernard Lethé Selected Research

HLA-A1 Antigen (HLA A1 Antigen)

3/2008Vaccination of a melanoma patient with mature dendritic cells pulsed with MAGE-3 peptides triggers the activity of nonvaccine anti-tumor cells.
1/2005Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen.
11/2003Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Bernard Lethé Research Topics

Disease

7Neoplasms (Cancer)
03/2014 - 01/2005
6Melanoma (Melanoma, Malignant)
02/2011 - 11/2003
2Neoplasm Metastasis (Metastasis)
02/2011 - 01/2005

Drug/Important Bio-Agent (IBA)

4AntigensIBA
02/2011 - 01/2005
3HLA-A1 Antigen (HLA A1 Antigen)IBA
03/2008 - 11/2003
3PeptidesIBA
03/2008 - 11/2003
2Neoplasm Antigens (Tumor Antigens)IBA
02/2011 - 01/2005
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
02/2011
1HLA-A2 Antigen (HLA A2 Antigen)IBA
02/2011
1Melanoma-Specific AntigensIBA
02/2011
1HLA-DP4IBA
03/2008
1Proteins (Proteins, Gene)IBA
11/2005
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
11/2005

Therapy/Procedure

3Immunotherapy
03/2014 - 06/2006
1Transplants (Transplant)
03/2014